antimony-sodium-gluconate has been researched along with Skin-Ulcer* in 8 studies
1 trial(s) available for antimony-sodium-gluconate and Skin-Ulcer
Article | Year |
---|---|
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.
A previously published proof of principle phase IIa trial with 113 patients from Kabul showed that bipolar high-frequency (HF) electro-cauterization (EC) of cutaneous leishmaniasis (CL) ulcers and subsequent moist wound treatment (MWT) closed 85% of all Leishmania (L.) tropica lesions within 60 days.. A three-armed phase IIb, randomized and controlled clinical trial was performed in Mazar-e-Sharif. L. tropica- or L. major-infected CL patients received intradermal sodium stibogluconate (SSG) (Group I); HF-EC followed by MWT with 0.045% DAC N-055 (Group II); or MWT with 0.045% DAC N-055 in basic crème alone (Group III). The primary outcome was complete epithelialisation before day 75 after treatment start.. 87 patients enrolled in the trial were randomized into group I (n = 24), II (n = 32) and III (n = 31). The per-protocol analysis of 69 (79%) patients revealed complete epithelialisation before day 75 in 15 (of 23; 65%) patients of Group I, in 23 (of 23; 100%) patients of Group II, and in 20 (of 23; 87%) patients of Group III (p = 0.004, Fisher's Exact Test). In the per-protocol analysis, wound closure times were significantly different between all regimens in a pair-wise comparison (p = 0.000039, Log-Rank (Mantel-Cox) test). In the intention-to-treat analysis wound survival times in Group II were significantly different from those in Group I (p = 0.000040, Log-Rank (Mantel-Cox) test). Re-ulcerations occurred in four (17%), three (13%) and seven (30%) patients of Group I, II or III, respectively (p = 0.312, Pearson Chi-Square Test).. Treatment of CL ulcers with bipolar HF-EC followed by MWT with 0.045% DAC N-055 or with DAC N-055 alone showed shorter wound closure times than with the standard SSG therapy. The results merit further exploration in larger trials in the light of our current knowledge of in vitro and in vivo activities of chlorite. Clinicaltrials.gov ID: NCT00996463. Registered: 15th October 2009. Topics: Adult; Afghanistan; Antimony Sodium Gluconate; Antiprotozoal Agents; Bandages; Chlorides; Electrocoagulation; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Skin Ulcer; Time Factors; Treatment Outcome; Wound Healing; Young Adult | 2014 |
7 other study(ies) available for antimony-sodium-gluconate and Skin-Ulcer
Article | Year |
---|---|
Ambiguous skin ulcer on the ear pinna.
Cutaneous leishmaniasis (CL) is a parasitic disease which has a biphasic life cycle; infection by promastigotes from the sandfly reaches a wound where it is phagocytosed by macrophages, producing the amastigote (the Leishmania donovani body) in the host. A protozoan parasite transmitted by the phlebotomous sandfly causes human leishmaniasis. Cutaneous forms include classical cutaneous, mucocutaneous and post-kala-azar dermal leishmaniasis. It affects c. 300 million individuals in more than 90 nations around the globe. The cutaneous form in the Old World is caused at low altitudes mainly by L. major (which has an animal reservoir, rodents such as mouse) and in swampy regions and high altitudes by L. tropica (which has no animal reservoir). L. aethiopica and L. major lead to disseminated ulcers in Saudi Arabia, Yemen, Iraq, Iran, Pakistan, India, Tunisia, Sudan and Ethiopia, whose main electrophoretic isozyme pattern Zymodeme in Saudi Arabia is LON-4. Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Ear Auricle; Humans; Leishmania donovani; Leishmaniasis, Cutaneous; Male; Skin Ulcer; Treatment Outcome | 2019 |
Imported new world cutaneous leishmaniasis in a traveller from Slovakia.
We present a case of imported leishmaniasis in a 31-year-old woman from Slovakia, who visited the countries of South America for three months in 2011. On 29 and 31 August 2011, she was probably infected with Leishmania parasites in the jungles of Ecuador. Approximately one week after returning to Slovakia, a small papules appeared on patient's left leg. Another wound was found after two weeks. Both ulcers were enlarging. We proved amastigote forms of Leishmania spp. only in repeated dermal scrapings from the edge of the ulcer by Giemsa staining after negative results from examination of a wound scrape and biopsy specimen. We identified the species Leishmania (Viannia) panamensis as a causative agent by using the polymerase chain reaction (PCR) method and subsequent sequencing of the ITS region. Closure of wounds and scab formation were observed after 20 days of treatment with sodium stibogluconate. In the control microscopic examination after the end of the treatment, parasites were not present, and the PCR confirmed the negative result (Fig. 2, Ref. 31). Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Transmission, Infectious; Ecuador; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Polymerase Chain Reaction; Skin Ulcer; Slovakia; Travel; Treatment Outcome; Wound Healing | 2015 |
Simultaneous infection with Leishmania (Viannia) braziliensis and L. (V.) lainsoni in a Peruvian patient with cutaneous leishmaniasis.
Conventional understanding suggests that simultaneous infection with more than one species of Leishmania is unlikely. In Peru, co-infections are clinically relevant because causative species dictates prognosis, treatment response, and follow-up. We describe a case of Leishmania (Viannia) braziliensis and L. (V.) lainsoni co-infection in a Peruvian patient with cutaneous leishmaniasis. Topics: Adult; Antimony Sodium Gluconate; Coinfection; DNA, Protozoan; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Skin Ulcer | 2013 |
Imported cutaneous leishmaniasis in a short-term traveler returning from Central Mali - The role of PCR.
Leishmaniasis is a parasitic infection caused by the obligate intracellular protazoa leishmania. The most commonly encountered form is cutaneous leishmaniasis (CL), which generally manifests as a chronic, painless ulcer. Recent increases in the incidence of CL worldwide due in large part to increased immigration and international travel, combined often with the lack of familiarity with the disease in non-endemic settings, pose the continued problems of delayed diagnosis and inappropriate treatment. A case is described of imported cutaneous leishmaniasis occurring in a 48 year-old male who presented with multiple painless, progressively ulcerating lesions after returning from a one week trip to Bandiagara, Mali, West Africa. After four months of misdiagnoses and ineffective treatments, he was referred to a tropical disease specialist where the diagnosis was made with a skin biopsy followed by a tissue impression smear, culture and PCR. Appropriate treatment was initiated and the lesions resolved with minimal scarring. The goals of this case report are threefold: first, to stress the importance of associating chronic ulcers in a traveler with potential cutaneous leishmaniasis; second, to emphasize the clinical utility of PCR for the diagnosis; and third, to discuss the clinical approach to treatment. Topics: Antimony Sodium Gluconate; Biopsy; Diagnosis, Differential; Disease Transmission, Infectious; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Mali; Middle Aged; Polymerase Chain Reaction; Skin Ulcer; Travel; Treatment Outcome | 2012 |
A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis.
Mucocutaneous leishmaniasis is a granulomatous disease clinically characterized by ulcerated skin and mucosal lesions. Mucocutaneous leishmaniasis is very rare in India and to our knowledge, only two cases have been reported, and this is the first case of mucocutaneous leishmaniasis presenting with mutilating rhinopathy reported from the Indian subcontinent.. A 64-year-old man presented with a destructive ulceration of the central face of 23 years' duration, who was diagnosed to have mucocutaneous leishmaniasis, and showed dramatic response to intramuscular injections of sodium stibogluconate.. Histopathologic examination of skin biopsy revealed a granulomatous infiltrate with the presence of leishmania donovani (LD) bodies. The clinical picture, plus the pathologic findings, and the response to sodium stibogluconate confirmed mucocutaneous leishmaniasis.. Mucocutaneous leishmaniasis is a rare disease in the Indian subcontinent, and clinicians from this region should have a high index of suspicion on encountering mucocutaneous ulcerative lesions. Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Progression; Humans; Leishmaniasis, Mucocutaneous; Male; Middle Aged; Nose Deformities, Acquired; Prostheses and Implants; Skin Ulcer; Time Factors | 2010 |
Rapid text referral.
Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Diagnosis, Differential; Humans; Infusions, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Remote Consultation; Skin Ulcer | 2006 |
Two cases of cutaneous Leishmaniasis presenting to the emergency department as chronic ulcers.
With the increasing numbers of travelers and immigrants coming to the United States from tropical areas where Leishmaniasis is endemic, it is important to be familiar with its common cutaneous manifestations. Leishmaniasis is a parasitic infection caused by the obligate intracellular protozoa Leishmania and is transmitted by the bite of the sandfly. It can appear as a nonhealing lesion on exposed skin in patients and is often misdiagnosed, delaying treatment. We present two cases of patients who presented to the Emergency Department with chronic, nonhealing ulcers that were ultimately found to have Leishmaniasis. Topics: Adult; Antimony Sodium Gluconate; Diagnosis, Differential; Emergency Service, Hospital; Female; Humans; Leishmaniasis, Cutaneous; Los Angeles; Male; Schistosomicides; Skin Ulcer; Travel | 2001 |